lapatinib
Showing 26 - 50 of 371
(Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive
Completed
- Breast Cancer
-
Shanghai, Shanghai, ChinaBiyun Wang, MD
Sep 29, 2020
Tumors, Breast Trial in La Jolla, Indianapolis, Greensboro (lapatinib, carboplatin, trastuzumab)
Completed
- Neoplasms, Breast
- lapatinib
- +3 more
-
La Jolla, California
- +2 more
Sep 8, 2020
Locally Advance Breast Cancer (LABC), Metastatic Breast Cancer (MBC) Trial in Madrid, Leicester, Manchester (BEZ235 +
Completed
- Locally Advance Breast Cancer (LABC)
- Metastatic Breast Cancer (MBC)
- BEZ235 + Trastuzumab Phase l/Phase ll)
- Lapatinib + Capecitabine (Phase II)
-
Madrid, Spain
- +2 more
Dec 6, 2020
Lapatinib Among Metastatic Breast Cancer Patients
Completed
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 21, 2020
Brain Cancer, Pediatric Cancers Trial in United States (Bevacizumab, Lapatinib)
Completed
- Brain Cancer
- Pediatric Cancers
- Bevacizumab
- Lapatinib
-
Stanford, California
- +5 more
Aug 14, 2020
Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)
Completed
- Cancer
- Advanced Solid Tumors
- Sunitinib
- +9 more
-
Amsterdam, NetherlandsVUMedical Center
Apr 14, 2021
HER2 Positive Breast Cancer Trial in Guangzhou (lapatinib and capecitabine or vinorelbine)
Completed
- HER2 Positive Breast Cancer
- lapatinib and capecitabine or vinorelbine
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 13, 2020
Decision-making of ctDNA in mCRC After Failure of First-line
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others
- (no location specified)
Apr 2, 2021
Tumors, Breast Trial in Worldwide (Lapatinib, Trastuzumab, Paclitaxel)
Completed
- Neoplasms, Breast
- Lapatinib
- +2 more
-
Berazategui, Buenos Aires, Argentina
- +121 more
Aug 24, 2021
Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)
Completed
- Advanced Cancer
- Bevacizumab
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
Breast Cancer Trial in United States (lapatinib ditosylate, paclitaxel albumin-stabilized nanoparticle formulation)
Completed
- Breast Cancer
- lapatinib ditosylate
- paclitaxel albumin-stabilized nanoparticle formulation
-
Chicago, Illinois
- +4 more
Feb 24, 2020
Advanced Solid Tumors, Inoperable, Metastasis Trial in Alkmaar, Amsterdam (desatinib or sunitinib or erlotinib or everolimus or
Terminated
- Advanced Solid Tumors
- +2 more
- desatinib or sunitinib or erlotinib or everolimus or lapatinib or sorafenib
-
Alkmaar, Netherlands
- +1 more
Nov 18, 2020
Pituitary Adenomas, Prolactinomas Trial in Los Angeles, Baltimore, Boston (Lapatinib)
Completed
- Pituitary Adenomas
- Prolactinomas
- Lapatinib
-
Los Angeles, California
- +2 more
Jan 13, 2020
HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,
Completed
- HER2-Positive Breast Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +301 more
Jun 28, 2022
Metastatic Colorectal Cancer Trial in Madison (lapatinib, Capecitabine)
Completed
- Metastatic Colorectal Cancer
- lapatinib
- Capecitabine
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Dec 11, 2019
Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous
Completed
- Head and Neck Cancer
- +19 more
- lapatinib ditosylate
- capecitabine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Mar 6, 2020
Breast Cancer Trial in Los Angeles (trastuzumab, lapatinib ditosylate)
Completed
- Breast Cancer
- trastuzumab
- lapatinib ditosylate
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020